President Trump held a listening session with pharmaceutical industry leaders and emphasized the need to make drugs more affordable while promoting innovation. He acknowledged the pharmaceutical industry's contributions but expressed concern about the high prices. Trump also discussed cutting regulations to encourage drug companies to bring back operations and jobs to the United States. He mentioned appointing a leader to streamline the FDA, reducing the time it takes to get new products on the market, and expressed surprise at the high cost and time it takes to develop new drugs.